Markets:

Overview

News

Currencies

International

Treasuries

Belite Bio, Inc - American Depositary Shares (NQ:BLTE)

160.27 +0.31 (+0.19%)

Streaming Delayed Price Updated: 9:33 AM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Belite Bio, Inc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >

Why Okta Is Trading Lower By Over 32%, Here Are 58 Stocks Moving In Thursday's Mid-Day Session ↗

September 01, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) jumped 94.4% to $27.24. ShiftPixy announced a 1-for-100 reverse stock split.

Via Benzinga

Nutanix, Five Below And Some Other Big Stocks Moving Higher On Thursday ↗

September 01, 2022

Forma Therapeutics Holdings, Inc. (NASDAQ: FMTX) jumped 48.5% to $19.90 after Novo Nordisk announced it will acquire the company for $20 per share in cash.

Via Benzinga

Belite Bio Starts Enrollment In Pivotal Lead Asset Study In Inherited Eye Disease ↗

August 22, 2022

Via Benzinga

10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others ↗

August 29, 2022

These names are benefitting from M&A, clinical data and promising regulatory actions.

Via Investor's Business Daily

Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday ↗

August 23, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of...

Via Benzinga

Vipshop Holdings, Signify Health And Other Big Gainers From Monday ↗

August 23, 2022

U.S. stocks closed sharply lower with the Nasdaq Composite dropping more than 300 points on Monday. Here is the list of some big stocks moving higher in the previous session.

Via Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 22, 2022

Via Benzinga

Belite Bio Shares Gain On Initiation Of Late-Stage Retinal Disease Study ↗

August 22, 2022

Belite Bio (NASDAQ: BLTE) has initiated enrollment for the U.S. Phase 3 clinical trial of its lead asset LBS-008 in patients with Stargardt Disease (STGD1), a progressively blinding disease with no...

Via Benzinga

Wayfair, Bed Bath & Beyond And Other Big Losers From Friday ↗

August 22, 2022

U.S. stocks closed lower with the Nasdaq Composite dropping 260 points on Friday. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday ↗

August 22, 2022

Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday.

Via Benzinga

'Novel Approach For Retinal Disease Needs' Stock Belite Bio Has 70% Potential Upside According To This Analyst ↗

August 01, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2022 ↗

August 01, 2022

Upgrades

Via Benzinga

WWE, Infrastructure and Energy Alternatives And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

July 25, 2022

Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) shares rose 26% to $13.14 in pre-market trading. MasTec announced plans to acquire Infrastructure and Energy Alternatives for $14 per share...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 22, 2022

Gainers

Via Benzinga

This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday ↗

July 22, 2022

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period...

Via Benzinga

Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday ↗

July 21, 2022

Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.

Via Benzinga

The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study ↗

July 20, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session ↗

July 20, 2022

Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year...

Via Benzinga

Recap of Tuesday's Biotech Catalysts - End Of The Day Summary ↗

July 19, 2022

The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness...

Via Benzinga

Belite Bio Seeks FDA Clearance For Late-Stage Genetic Eye Disease Study ↗

July 19, 2022

Belite Bio (NASDAQ: BLTE) submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to support Phase 3 development of its lead asset LBS-008 for treatment...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 06, 2022

Via Benzinga

Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday ↗

July 05, 2022

Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2022 ↗

July 01, 2022

Upgrades

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; US Retail Sales Drop In May ↗

June 15, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 14, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 14, 2022

Via Benzinga

82 Biggest Movers From Yesterday ↗

June 15, 2022

Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tuesday.

Via Benzinga

41 Stocks Moving In Tuesday's Mid-Day Session ↗

June 14, 2022

Gainers Revlon, Inc. (NYSE: REV) rose 125.5% to $2.6499. Revlon’s stock dropped sharply on Monday after the company is reportedly expected to file for bankruptcy.

Via Benzinga

93 Biggest Movers From Yesterday ↗

June 14, 2022

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in...

Via Benzinga

70 Stocks Moving In Monday's Mid-Day Session ↗

June 13, 2022

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

END-OF-YEAR DRIVE: HOW YOU CAN HELP SUPPORT LOCAL NEWS

Belite Bio, Inc - American Depositary Shares (NQ:BLTE)

All News about Belite Bio, Inc - American Depositary Shares

The Newspapers of New England Family

We continue to need local support from our readers

Enjoying the Concord Monitor?

END-OF-YEAR DRIVE: HOW YOU CAN HELP SUPPORT LOCAL NEWS

Belite Bio, Inc - American Depositary Shares (NQ:BLTE)

All News about Belite Bio, Inc - American Depositary Shares

Sign in